A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission

DOI: 10.3390/cancers8040046

Keywords: peptide vaccine, unimolecular vaccine, QS-21, ovarian cancer, remission, immunogenicity

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text